Prostate Small Cell Carcinoma Active Not Recruiting Phase 2 Trials for Cediranib (DB04849)

IndicationStatusPhase
DBCOND0082092 (Prostate Small Cell Carcinoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02893917Olaparib With or Without Cediranib in Treating Patients With Metastatic Castration-Resistant Prostate CancerTreatment